Notably, heightened PNN expression levels have been documented in gastrointestinal neoplasms, rendering it a viable independent prognostic indicator and immunotherapeutic response predictor in colon adenocarcinoma (COAD) [47]. The gene discussed is PNN; the disease is digestive system neoplasm.